Categories: Nigeria News

BREAKING: NAFDAC approves emergency use of Johnson & Johnson COVID-19 vaccine

The National Agency for Food and Drug Administration and Control (NAFDAC) on Tuesday gave Janssen (Johnson and Johnson) COVID-19 vaccine the nod for conditional emergency use for Nigerians from 18 years

Director-General of the agency, Prof. Mojisola Adeyeye, made this known in a statement in Abuja.

She said: “After a thorough evaluation, the NAFDAC vaccine committee concluded that the data on the vaccine were robust and met criteria for efficacy, safety and quality.

“Thee data also show that the vaccine’s known and potential benefits outweigh its known and potential risks thereby supporting the manufacturer’s recommended use. Janssen COVID-19 Vaccine is the third vaccine recommended in Nigeria for preventing COVID-19.

“The Janssen COVID-19 vaccine is administered as a single dose. Results from a clinical trial involving people in the United States, South Africa and Latin American countries found that Janssen COVID-19 Vaccine was effective at preventing COVID-19 in people from 18 years of age.

“The Phase III clinical trial involved over 44,000 people. Half received a single dose of the vaccine and half were given placebo (a dummy injection). People did not know if they had been given Janssen COVID-19 Vaccine or placebo.

“The trial found a 67 percent reduction in the number of symptomatic COVID-19 cases after 2 weeks in people who received Janssen COVID-19 Vaccine.

“The most commonly reported side effects were pain at the injection site, headache, fatigue, muscle aches and nausea. Most of these side effects were mild to moderate in severity and lasted 1-2 days.”

On safety of the vaccine, the NAFDAC boss added: “In line with the NAFDAC’s Pharmacovigilance and safety monitoring plan for COVID-19 vaccines, Janssen COVID-19 vaccine will be closely monitored and subject to several activities that apply specifically to COVID-19 vaccines.

“Manufacturers are required to provide monthly safety reports in addition to the regular updates generated by NAFDAC activities. Janssen COVID-19 Vaccine works by preparing the body to defend itself against COVID-19.

“Unopened vaccine vials can be stored and/or transported frozen at -25°C to – 15°C for up to 24 months and 3 months when stored at 2 to 8°C.

“The Ministry of Health and National Primary Health Care Development Agency will announce when the vaccine becomes available for use in Nigeria.”

Idoko Dennis

Idoko Dennis is a creative videographer/drone pilot and sport writer. He heads the sport desk and deputizes the head of Idoma TV

Recent Posts

Guinea’s Junta leader, Mamady Doumbouya elevates himself to Army General

Guinea's junta leader, Mamady Doumbouya, has elevated himself to the rank of army general as…

2 hours ago

Full list of what Tinubu achieved in October

The media team of President Bola Ahmed Tinubu has unveiled the administration's scorecard for October,…

2 hours ago

Food insecurity crisis: UN predicts 7 million more hungry Nigerians by August 2025

The United Nations (U.N.) has projected that an additional 7 million Nigerians will face hunger…

10 hours ago

Latest update on fuel price hike, fuel scarcity for November 2nd, 2024

As Nigerians express their frustrations over the recent fuel price hikes by the Nigerian National…

10 hours ago

Electricity restored in Yobe, Borno States as TCN completes transmission line repairs

The Transmission Company of Nigeria (TCN) has announced the full restoration of electricity supply to…

10 hours ago

Naira appreciates by 0.52% against Dollar, closing at N1,666.72

The Naira experienced an appreciation on Friday at the official market, with a trading rate…

10 hours ago